Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Weight loss jabs linked to ‘severe’ stomach problems, says study

Using weight loss jabs could increase the risk of developing “severe” gastrointestinal problems, according to a study.

US researchers said semaglutide, marketed as Wegovy or Ozempic, could heighten the probability of pancreatitis, bowel obstructions and “stomach paralysis” in non-diabetics.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.